Exagen Inc (XGN)

05:57 AM

Exagen CEO, President & Director Acquires 7.7% More Stock - Simply Wall St

05:57 AM

03:19 AM

Exagen stock soars to 52-week high, hits $3.79 By Investing.com - Investing.com Australia

03:19 AM

Nov 20, 2024

Exagen stock soars to 52-week high, hits $3.79 - Investing.com India

Nov 20, 2024

Nov 20, 2024

Exagen CFO Jeffrey Black acquires $66,448 in common stock - Investing.com India

Nov 20, 2024

Nov 18, 2024

Exagen president and CEO John Aballi buys $68,297 in stock - Investing.com

Nov 18, 2024

Nov 18, 2024

What is William Blair’s Forecast for Exagen FY2024 Earnings? - Defense World

Nov 18, 2024

Nov 18, 2024

Research Analysts Issue Forecasts for Exagen FY2024 Earnings - MarketBeat

Nov 18, 2024

Nov 18, 2024

FY2024 EPS Estimates for Exagen Raised by Cantor Fitzgerald - MarketBeat

Nov 18, 2024

Nov 18, 2024

Cantor Fitzgerald Increases Earnings Estimates for Exagen - Defense World

Nov 18, 2024

Nov 15, 2024

Exagen Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

William Blair Reiterates “Outperform” Rating for Exagen (NASDAQ:XGN) - Defense World

Nov 15, 2024

Nov 14, 2024

Exagen unveils new biomarkers to enhance autoimmune testing - Investing.com

Nov 14, 2024

Nov 14, 2024

Exagen Inc. Completes Validation and Regulatory Submission - GlobeNewswire

Nov 14, 2024

Nov 14, 2024

Exagen Enhances AVISE CTD Platform with 7 New Biomarkers for Autoimmune Disease Detection | XGN Stock News - StockTitan

Nov 14, 2024

Nov 13, 2024

Exagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

Exagen Inc. to Participate in Fourth Quarter Investor Conferences - The Manila Times

Nov 13, 2024

Nov 13, 2024

Exagen stock holds Sector Weight amid mixed 3Q24 results By Investing.com - Investing.com Australia

Nov 13, 2024

Nov 13, 2024

Exagen CEO to Present at Three Major Healthcare Investor Conferences | XGN Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

Exagen (NASDAQ:XGN) Receives Outperform Rating from William Blair - MarketBeat

Nov 13, 2024

Nov 13, 2024

Exagen Inc. (NASDAQ:XGN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 13, 2024

Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Ch - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

Exagen Inc. Reports Q3 2024 Financial Results - TipRanks

Nov 12, 2024

Nov 12, 2024

Exagen Inc. (XGN) Quarterly 10-Q Report - Quartzy

Nov 12, 2024

Nov 12, 2024

Exagen stock holds Sector Weight amid mixed 3Q24 results - Investing.com

Nov 12, 2024

Nov 12, 2024

Exagen Inc. (XGN) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 12, 2024

Nov 12, 2024

Exagen Inc (XGN) Q3 2024 Earnings: Revenue Misses Estimates at $12.5M, Net Loss Narrows to $5.0M - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

Exagen Inc. Reports Third Quarter 2024 Results - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Exagen Q3 Revenue Hits $12.5M Despite Setbacks; YTD Performance Shows 37% Loss Reduction | XGN Stock News - StockTitan

Nov 12, 2024

Nov 11, 2024

Exagen Inc (XGN) Q3 2024 Earnings Report Preview: What To Expect - GuruFocus.com

Nov 11, 2024

Nov 10, 2024

Exagen (XGN) to Release Earnings on Tuesday - Defense World

Nov 10, 2024

Oct 29, 2024

Exagen to Announce Third Quarter 2024 Results on November 12, 2024 - GlobeNewswire

Oct 29, 2024

Oct 22, 2024

Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence - The Manila Times

Oct 22, 2024

Oct 14, 2024

Renaissance Technologies LLC Boosts Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World

Oct 14, 2024

Oct 12, 2024

Exagen Insider Stock Sales Prove Timely As Market Valuation Descends To US$47m - Simply Wall St

Oct 12, 2024

Oct 01, 2024

Stonepine Capital Management LLC Has $653,000 Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World

Oct 01, 2024

Oct 01, 2024

Exagen Inc. (NASDAQ:XGN) Shares Sold by Nantahala Capital Management LLC - Defense World

Oct 01, 2024

Sep 30, 2024

Exagen's SWOT analysis: diagnostic firm's stock poised for growth amid challenges - Investing.com

Sep 30, 2024

Sep 28, 2024

Exagen Inc. (NASDAQ:XGN) Short Interest Up 20.9% in September - MarketBeat

Sep 28, 2024

Sep 25, 2024

Octopus Energy acquires solar and storage company Exagen Group - Yahoo Finance

Sep 25, 2024

Sep 24, 2024

Octopus buys British solar and battery storage firm Exagen - Reuters

Sep 24, 2024

Sep 23, 2024

PARP Inhibitor Biomarkers Market Expected to Reach $1.75 Billion by 2031 - WhaTech

Sep 23, 2024

Sep 20, 2024

Autoimmune Disease Diagnostics Market 2024 Global Insights and Business Scenario 2031 - Newstrail

Sep 20, 2024

Sep 18, 2024

San Diego 2024 Top Tech Awards ceremony set for Sept. 26 at Snapdragon Stadium - CBS News 8

Sep 18, 2024

Sep 18, 2024

Autoimmune Disease Testing Market to Reach $12.1 Billion, Globally, by 2033 at 8.6% CAGR: Allied Market Research - PR Newswire UK

Sep 18, 2024

Sep 13, 2024

Bears are Losing Control Over Exagen (XGN), Here's Why It's a 'Buy' Now - MSN

Sep 13, 2024

Sep 13, 2024

Shareholders in Exagen (NASDAQ:XGN) have lost 84%, as stock drops 12% this past week - Yahoo Finance

Sep 13, 2024

Sep 10, 2024

PARP Inhibitor Biomarkers Market to Surge with 8.8% CAGR by 2031 - WhaTech

Sep 10, 2024

Sep 06, 2024

Improved Revenues Required Before Exagen Inc. (NASDAQ:XGN) Stock's 40% Jump Looks Justified - Simply Wall St

Sep 06, 2024

Sep 04, 2024

Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference - ForexTV.com

Sep 04, 2024